NCT05183542

Brief Summary

The hypothesis of our study is that SPECT/CT bone scan fixation quantified by SUVMAX on a CZT solid state camera preoperatively would identify good responders to lumbar arthrodesis surgery.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 21, 2021

Completed
20 days until next milestone

First Posted

Study publicly available on registry

January 10, 2022

Completed
4 months until next milestone

Study Start

First participant enrolled

April 29, 2022

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 29, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 29, 2025

Completed
Last Updated

January 8, 2025

Status Verified

January 1, 2025

Enrollment Period

3.6 years

First QC Date

December 21, 2021

Last Update Submit

January 7, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • To determine if there is a correlation of SUV value and response to surgery with ODI

    To determine whether SUVmax (Standard Uptake Value) measured at late time on bone scan, predicts a good response to lumbar arthrodesis surgery according to the Oswestry Disability Index (ODI) measured at 12 months after surgery

    24 months

Secondary Outcomes (3)

  • To determine if there is a correlation of SUV value and response to surgery with NS

    24 months

  • To determine if there is a correlation of SUV value at early time and response to surgery with ODI

    24 months

  • To determine if there is a correlation of SUV value at early time and response to surgery with NS

    24 months

Study Arms (1)

Patients

EXPERIMENTAL

Patients with bone scan

Drug: Bone scan

Interventions

Persons to be operated on for lumbar arthrodesis by the neurosurgery team of the Nancy CHRU and respecting the eligibility criteria (including a score of neuropathique pain scale \< 4, see non-inclusion criteria), will be proposed to participate in the study neuropathic pain If they give their oral agreement to the neurosurgeon, a request for a bone scan will be sent to the nuclear medicine department of the Nancy-Brabois Hospital. The patients will fill pain scales before and after surgery (ODI and NS)

Also known as: Scales of pain
Patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Persons with back pain for at least 3 months (presumed to be due to degenerative disc disease or spondylolisthesis).
  • Persons who have received full information about the organisation of the research and have signed the informed consent and :
  • Age ≥ 18 years, having read and understood the information document.
  • Affiliated to a social security scheme.
  • Lumbar arthrodesis involving a maximum of 2 floors.
  • Standardized lumbar arthrodesis surgery performed by one of the three senior neurosurgeons of the neurosurgery department of the Nancy CHRU, using similar surgical techniques.

You may not qualify if:

  • Low back pain of neuropathic origin. The Neuropathic Pain Scale 4 questionnaire is used to diagnose neuropathic pain (score is ≥ 4/10)
  • History of lumbar spine surgery
  • Presence of other pathologies responsible for lumbar pain (multistage discopathies, ankylosing spondylitis, spondylodiscitis, rheumatoid arthritis, vertebral compression, vertebral metastasis, narrow lumbar canal, scoliosis, spondylolisthesis by isthmic lysis)
  • Pregnant women or women of childbearing age without suitable contraception or nursing mothers.
  • Unstable medical condition and/or inability to remain immobile in supine position during recordings.
  • Known allergy to any component of the radiopharmaceutical (TECHNESCAN HDP).
  • Person referred to in Articles L. 1121-5, L. 1121-7 and L1121-8 of the Public Health Code.
  • Persons deprived of their liberty by a judicial or administrative decision, persons under psychiatric care by virtue of Articles L. 3212-1 and L. 3213-1.
  • Persons of full age who are unable to express their opposition.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nuclear Medicine Department

Vandœuvre-lès-Nancy, 54511, France

RECRUITING

Study Officials

  • El Mehdi SIAGHY, PhD

    CHRU Nancy

    STUDY DIRECTOR

Central Study Contacts

Achraf BAHLOUL, MD

CONTACT

Véronique ROCH, MSc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Model Details: Persons to be operated on for lumbar arthrodesis by the neurosurgery team of the Nancy CHRU and respecting the eligibility criteria (including neuropathic pain scale score \< 4, see non-inclusion criteria), will be proposed to participate in the study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

December 21, 2021

First Posted

January 10, 2022

Study Start

April 29, 2022

Primary Completion

November 29, 2025

Study Completion

November 29, 2025

Last Updated

January 8, 2025

Record last verified: 2025-01

Locations